A Comprehensive Study on COVID-19 Epidemiology, Anatomical Assemblage and Its Mechanism

Author(s):  
Sameer Sharma ◽  
◽  
Chourasiya R ◽  
Susha D ◽  
◽  
...  

The COVID-19, or also called SARS-CoV-2, which is causative agent of probably inevitable disease which is of big global public health problem. COVID-19 is a positive stranded RNA virus that is majorly found in wildlife & humans. And the outbreak of Novel Coronavirus is unleashing chaos across the world due to inadequate risk assessment with reference to insistence of problem. The COVID-19 pandemic has enrolled in a critical novel phase. When compared to MERS & SARS, SARS-CoV-2 has transmitted more rapidly, because of increased globalization and adaptation of Novel coronavirus. However, the recent outbreak of COVID-19 showing an immediate requirement for therapeutics targeting SARS-CoV-2. Here, we have discussed the different symptoms in COVID-19, SARS, MERS & common flu as well as structure of virus regarding its immune response and we are providing a brief about the Indian traditional plants as conceivable novel therapeutic pathways.

2022 ◽  
pp. 389-411
Author(s):  
Rafael Vargas-Bernal

Since the end of 2019, the SARS-CoV-2 virus, commonly known as COVID-19, has become an infectious disease that has produced a severe global public health problem that requires solutions from different scientific initiatives. Nanomaterials are used to diagnose, treat, and prevent the SARS-CoV-2 virus. Its potential is highlighted through specific applications and developments carried out by researchers around the world. In addition to highlighting the characteristics and properties of the COVID-19 virus, the purpose of the chapter is focused on describing the role that nanomaterials are playing and that must be overcome due to the pandemic. Future research directions are described to guide readers on the innovations that are required related to the diagnosis, treatment, and prevention of SARS-CoV-2 and its variants. The impact that nanomaterials will have on COVID-19 will reduce the time for humans to return to the rhythm of life before the pandemic.


2020 ◽  
Vol 04 (01) ◽  
pp. 40-46
Author(s):  
Chitra Mehta ◽  
Sushila Kataria ◽  
Yatin Mehta

AbstractCoronavirus 2019 (COVID-19) disease is the most recent global public health problem. It is caused by SARS-CoV-2 (severe acute respiratory syndrome related coronavirus 2), which is a RNA virus with a high mutation rate, belonging to the genus Coronavirus. The objective of this communication is to provide an initial understanding regarding pathophysiology, clinical manifestations, management, and prevention of this devastating disease.


2020 ◽  
Vol 8 (9) ◽  
pp. 1259 ◽  
Author(s):  
Shiu-Jau Chen ◽  
Shao-Cheng Wang ◽  
Yuan-Chuan Chen

The coronavirus disease 2019 (COVID-19) pandemic, caused by severe acute respiratory syndrome coronavirus-2 (SARS–CoV-2), is still a global public health problem for humans. It has caused more than 10,000,000 infections and more than 500,000 deaths in the world so far. Many scientists have tried their best to discover safe and effective drugs for the treatment of this disease; however, there are still no approved standard therapeutics or effective antiviral drugs on the market. Many new drugs are being developed, and several traditional drugs that were originally indicated or proposed for other diseases are likely to be effective in treating COVID-19, but their safety and efficacy are controversial, under study, or in clinical trial phases. Fortunately, some novel antiviral strategies, such as convalescent plasma, clustered regularly interspaced short palindromic repeats (CRISPR), and mesenchymal stem cell (MSC) therapy, potentially offer an additional or alternative option or compassionate use for the people suffering from COVID-19, especially for critically ill patients, although their safety and efficacy are also under study. In this review, we explore the applications, possible mechanisms, and efficacy in successful cases using convalescent plasma, CRISPR, and MSC therapy for COVID-19 treatment, respectively. Furthermore, the perspectives and limitations of these novel antiviral strategies are evaluated.


2020 ◽  
Author(s):  
Helmi Zakariah ◽  
Fadzilah bt Kamaluddin ◽  
Choo-Yee Ting ◽  
Hui-Jia Yee ◽  
Shereen Allaham ◽  
...  

UNSTRUCTURED The current outbreak of coronavirus disease 2019 (COVID-19) caused by the novel coronavirus named SARS-CoV-2 has been a major global public health problem threatening many countries and territories. Mathematical modelling is one of the non-pharmaceutical public health measures that plays a crucial role for mitigating the risk and impact of the pandemic. A group of researchers and epidemiologists have developed a machine learning-powered inherent risk of contagion (IRC) analytical framework to georeference the COVID-19 with an operational platform to plan response & execute mitigation activities. This framework dataset provides a coherent picture to track and predict the COVID-19 epidemic post lockdown by piecing together preliminary data on publicly available health statistic metrics alongside the area of reported cases, drivers, vulnerable population, and number of premises that are suspected to become a transmission area between drivers and vulnerable population. The main aim of this new analytical framework is to measure the IRC and provide georeferenced data to protect the health system, aid contact tracing, and prioritise the vulnerable.


2016 ◽  
Vol 27 (1) ◽  
pp. 31-35
Author(s):  
Montosh Kumar Mondal ◽  
Beauty Rani Roy ◽  
Shibani Banik ◽  
Debabrata Banik

Medication error is a major cause of morbidity and mortality in medical profession . There is an increasing recognition that medication errors are causing a substantial global public health problem, as many result in harm to patients and increased costs to health providers.Anaesthesia is now safe and routine, yet anaesthetists are not immune from making medication errors and the consequences of their mistakes may be more serious than those of doctors in other specialties. Steps are being taken to determine the extent of the problem of medication error in anaesthesia. In this review, incidence, types, risk factors and preventive measures of the medication errors are discussed in detail.Journal of Bangladesh Society of Anaesthesiologists 2014; 27(1): 31-35


2021 ◽  
Vol 7 (1) ◽  
pp. e19-e19
Author(s):  
Alireza Pouramini ◽  
Fatemeh Kafi ◽  
Shakiba Hassanzadeh

COVID-19 infection increases the risk of death in patients with chronic conditions such as diabetes or obesity. The exact role of vitamin D in COVID-19 infection is unknown and controversial. Furthermore, the exact prevalence of vitamin D deficiency is still unknown but it affects individuals worldwide regardless of ethnicity and age. Herein, we give an overview of vitamin D deficiency as a global public health problem, the role of vitamin D in COVID-19 infection, and the proper approach to treating vitamin D deficiency.


2021 ◽  
Vol 9 (9) ◽  
pp. 2144-2150
Author(s):  
Shivam Kumar Nigam ◽  
Rita Singh ◽  
Sanjay Srivastava

Pandu Roga is one of the diseases mentioned in Ayurveda characterized by the changes in the skin colour to white (Shweta), yellowish (Peeta), greenish (Harita) etc. which is one of the “Varnopalakshita Roga" i.e., a disease characterized by the change in the colour. The clinical condition of Pandu in Ayurveda can be co-related with Anaemia described in Modern Medical Science, due to the resemblance in the clinical signs and symptoms. In Modern Medicine, Pandu is a pale appearance which may be due to the decreased blood supply to the skin or de- creased visibility of oxyhemoglobin. Anaemia is a major global public health problem and the most prevalent nu- tritional deficiency disorder in the world. This article presents the Ayurvedic concept of Pandu Roga (Anaemia). Keywords: Pandu, Vyadhi, Srotas, Anaemia, Pallor,


Sign in / Sign up

Export Citation Format

Share Document